Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene citrate for testosterone deficiency
NCT05096169Phase 2Withdrawn
- Sponsor
- Weill Cornell Medicine
- Start
- May 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clomiphene in testosterone deficiency (TD), sponsored by Weill Cornell Medicine. Planned start May 2022; status: withdrawn.
02
Drugs
clomiphene
03
Conditions
testosterone deficiency (TD)
Beyond the preview
Go deeper on NCT05096169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096169.